46 results
Safety and Tolerability of Cariprazine for the Adjunctive Treatment of Major Depressive Disorder: A Pooled Analysis of Phase 2B and 3 Clinical Trials
-
- Journal:
- CNS Spectrums / Volume 28 / Issue 2 / April 2023
- Published online by Cambridge University Press:
- 14 April 2023, pp. 255-256
-
- Article
-
- You have access
- Export citation
The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression
-
- Journal:
- CNS Spectrums / Volume 28 / Issue 4 / August 2023
- Published online by Cambridge University Press:
- 15 July 2022, pp. 427-440
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Clinical research challenges posed by difficult-to-treat depression
-
- Journal:
- Psychological Medicine / Volume 52 / Issue 3 / February 2022
- Published online by Cambridge University Press:
- 07 January 2022, pp. 419-432
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Safety of Using a Combinatorial Pharmacogenomic Test for Patients with Major Depressive Disorder in the GUIDED trial
-
- Journal:
- CNS Spectrums / Volume 26 / Issue 2 / April 2021
- Published online by Cambridge University Press:
- 10 May 2021, pp. 169-170
-
- Article
-
- You have access
- Export citation
Evaluation of MADRS Severity Thresholds in Patients With Bipolar Depression
-
- Journal:
- CNS Spectrums / Volume 26 / Issue 2 / April 2021
- Published online by Cambridge University Press:
- 10 May 2021, pp. 182-183
-
- Article
-
- You have access
- Export citation
Healthcare Provider Perspectives on Bipolar I Disorder Screening and the Rapid Mood Screener (RMS), a Pragmatic, New Tool
-
- Journal:
- CNS Spectrums / Volume 26 / Issue 2 / April 2021
- Published online by Cambridge University Press:
- 30 April 2021, p. 181
-
- Article
-
- You have access
- Export citation
180 Improvement of Sexual Function Observed During Treatment of Major Depressive Disorder with Adjunctive Pimavanserin
-
- Journal:
- CNS Spectrums / Volume 25 / Issue 2 / April 2020
- Published online by Cambridge University Press:
- 24 April 2020, pp. 313-314
-
- Article
-
- You have access
- Export citation
181 A Phase-2 Sequential Parallel Comparison Design Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder
-
- Journal:
- CNS Spectrums / Volume 25 / Issue 2 / April 2020
- Published online by Cambridge University Press:
- 24 April 2020, pp. 314-315
-
- Article
-
- You have access
- Export citation
150 HAM-D6 Outcomes in a Randomized, Controlled Trial Evaluating the Utility of Combinatorial Pharmacogenomics in Depression
-
- Journal:
- CNS Spectrums / Volume 25 / Issue 2 / April 2020
- Published online by Cambridge University Press:
- 24 April 2020, pp. 295-296
-
- Article
-
- You have access
- Export citation
Response to the letter entitled “Tachyphylaxis and Desensitization Depression” by Richard Skaff
-
- Journal:
- CNS Spectrums / Volume 26 / Issue 3 / June 2021
- Published online by Cambridge University Press:
- 21 November 2019, pp. 193-194
-
- Article
-
- You have access
- HTML
- Export citation
Correlation between white blood cell count and mood-stabilising treatment response in two bipolar disorder trials
-
- Journal:
- Acta Neuropsychiatrica / Volume 31 / Issue 4 / August 2019
- Published online by Cambridge University Press:
- 06 June 2019, pp. 230-234
-
- Article
- Export citation
50 Adjunctive Buprenorphine/Samidorphan Combination in Patients with Major Depressive Disorder: Phase 3 Long-term Extension Study Results
-
- Journal:
- CNS Spectrums / Volume 24 / Issue 1 / February 2019
- Published online by Cambridge University Press:
- 12 March 2019, pp. 203-204
-
- Article
-
- You have access
- Export citation
49 Combinatorial Pharmacogenomics to Guide Treatment Selection for Major Depressive Disorder: A Large, Blinded, Randomized Controlled Trial
-
- Journal:
- CNS Spectrums / Volume 24 / Issue 1 / February 2019
- Published online by Cambridge University Press:
- 12 March 2019, pp. 202-203
-
- Article
-
- You have access
- Export citation
32 - Management Commentary
- from Section 2 - Management Commentaries
-
-
- Book:
- Bipolar II Disorder
- Published online:
- 17 December 2018
- Print publication:
- 03 January 2019, pp 272-275
-
- Chapter
- Export citation
New medications for treatment-resistant depression: a brief review of recent developments
-
- Journal:
- CNS Spectrums / Volume 22 / Issue S1 / December 2017
- Published online by Cambridge University Press:
- 19 January 2018, pp. 39-48
-
- Article
- Export citation
Ketamine: stimulating antidepressant treatment?
- Part of
-
- Journal:
- BJPsych Open / Volume 2 / Issue 3 / May 2016
- Published online by Cambridge University Press:
- 02 January 2018, pp. e5-e9
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Clinically relevant and simple immune system measure is related to symptom burden in bipolar disorder
-
- Journal:
- Acta Neuropsychiatrica / Volume 30 / Issue 5 / October 2018
- Published online by Cambridge University Press:
- 07 December 2017, pp. 297-305
-
- Article
- Export citation
Measures of suicidality in phase 3 clinical trials of levomilnacipran ER in adults with major depressive disorder
-
- Journal:
- CNS Spectrums / Volume 22 / Issue 6 / December 2017
- Published online by Cambridge University Press:
- 19 May 2017, pp. 475-483
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Lurasidone for major depressive disorder with mixed features and anxiety: a post-hoc analysis of a randomized, placebo-controlled study
-
- Journal:
- CNS Spectrums / Volume 22 / Issue 2 / April 2017
- Published online by Cambridge University Press:
- 30 March 2017, pp. 236-245
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Guidelines for the recognition and management of mixed depression
-
- Journal:
- CNS Spectrums / Volume 22 / Issue 2 / April 2017
- Published online by Cambridge University Press:
- 28 February 2017, pp. 203-219
-
- Article
-
- You have access
- Open access
- HTML
- Export citation